NDC 50090-1006-01 - Glimepiride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-1006
- Requested NDC
- 50090-1006-01
- Package NDCs from labels
- 50090-1006-0, 50090-1006-3, 50090-1006-4, 50090-1006-1, 50090-1006-2, 50090-1006-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glimepiride - A-S Medication Solutions | A-S Medication Solutions | 2023-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-1006-0 | Glimepiride | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 50090-1006-1 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 50090-1006-2 | Glimepiride | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 50090-1006-3 | Glimepiride | 90 in 1 BOTTLE | TABLET | 90 | 3 | |
| 50090-1006-4 | Glimepiride | 180 in 1 BOTTLE | TABLET | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-1006 | GLIMEPIRIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 5 package rows | 20230623_def20e38-01f7-4ead-beb6-3dc11062a342.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-1006-0 | EA - Each | 50090-1006 | 4726f8f7-6b3d-46db-8ca6-a2dc7f605bbd | 1 | 2023-05-05 |
| 50090-1006-1 | EA - Each | 50090-1006 | 11f2ceef-290a-4fe0-8159-f93d9811450b | 1 | 2023-05-05 |
| 50090-1006-2 | EA - Each | 50090-1006 | ae9ebe9b-c8ff-4938-8f71-4eb124757b16 | 1 | 2023-05-05 |
| 50090-1006-3 | EA - Each | 50090-1006 | 0057bd01-84f2-45e0-8f1d-0d171db7af6f | 1 | 2023-05-05 |
| 50090-1006-4 | EA - Each | 50090-1006 | 6811f6b5-c6d1-4edf-9199-accb2e980837 | 1 | 2023-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equaline Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | United Natural Foods, Inc. | f7602789-179a-edfc-e053-6294a90a0844 | 2023-12-20 | Warnings | FZ989GH94E |
| Topcare Health Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | Topco Associates LLC | 9c614c0e-5862-682f-e053-2a95a90abc09 | 2023-12-20 | Warnings | FZ989GH94E |
| TopCare Health Advanced Moisturizing Plus Redness Relief | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Topco Associates LLC | 9c6193a6-d822-1b27-e053-2995a90ab3cf | 2023-12-20 | Warnings | FZ989GH94E |
| HEB Advanced Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE | HEB Grocery Company, LP | f76281d6-3aea-349b-e053-6394a90afca2 | 2023-12-20 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | be772fca-1579-4fba-a4b7-04b970d09e45 | 2023-12-17 | Warnings, Adverse reactions | ANDA077091 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | 0a1eaf23-d5fd-4b3e-96c5-68ff16f0033b | 2023-12-14 | Warnings, Adverse reactions | ANDA077091 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | a9461830-1c4f-4bc4-b622-1c44112a76b9 | 2023-12-03 | Warnings, Adverse reactions | ANDA077091 199247 6KY687524K |
| Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Proficient Rx LP | 73e12596-6dd5-4cd2-83ed-992e1211b4b8 | 2023-12-01 | Warnings | FZ989GH94E |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | a11680ba-2750-43ab-a1b1-a52ebe3e139f | 2023-09-06 | Warnings, Adverse reactions | 199247 6KY687524K |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | e8da2484-43a7-4dcb-84d5-d84596feb9f6 | 2023-08-31 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | A-S Medication Solutions | def20e38-01f7-4ead-beb6-3dc11062a342 | 2023-06-22 | Warnings, Adverse reactions | ANDA077091 50090-1006-1 50090-1006-3 50090-1006-0 50090-1006-4 50090-1006-2 50090-1006 50090100601 199247 8c26254a-c103-49d1-a1e4-8f256ef48805 def20e38-01f7-4ead-beb6-3dc11062a342 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 8f687fa6-54eb-4556-8ea6-aafec49a87d1 | 2023-03-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | beb0cefb-807b-4cc3-ada2-7a8ed4aa8f2b | 2022-10-01 | Warnings, Adverse reactions | 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 5a5747ea-cded-49ed-8807-dd3e2a1159e0 | 2022-10-01 | Warnings, Adverse reactions | 199245 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 68cb4fcd-5bc3-4f53-9085-86df6a4246d6 | 2022-04-01 | Warnings, Adverse reactions | 199247 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Solco Healthcare U.S., LLC | 86acdd9e-8637-43e4-8bf7-b3a123b871b8 | 2021-08-13 | Warnings, Adverse reactions | 199247 199245 199246 6KY687524K |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | ebb9f080-b11d-5d18-36f0-627107e7fbcd | 2020-08-27 | Warnings, Adverse reactions | ANDA077091 199246 6KY687524K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.